We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK May Allow Early Access to Drugs Based on Strong Phase II, III Trials
UK May Allow Early Access to Drugs Based on Strong Phase II, III Trials
August 15, 2012
Strong Phase III or even Phase II data may enable drugmakers to sell certain medicines for unmet needs in the UK before they are approved, thanks to a developing early access program.